Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s share price fell 4.3% on Friday . The stock traded as low as $1.11 and last traded at $1.12. 88,090 shares changed hands during mid-day trading, an increase of 31% from the average session volume of 67,097 shares. The stock had previously closed at $1.17.
Cardiol Therapeutics Price Performance
The company’s 50 day simple moving average is $1.24 and its two-hundred day simple moving average is $1.57.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
Featured Stories
- Five stocks we like better than Cardiol Therapeutics
- Stock Market Upgrades: What Are They?
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Retail Stocks Investing, Explained
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Consumer Discretionary Stocks Explained
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
